COVID-19 Diagnostics Market Size 2021 | Is Projected to Reach USD 6.22 Billion by 2027, Exhibiting a CAGR of 2.7%
May 10, 2021 07:17 ET
|
Fortune Business Insights
Pune, India, May 10, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 6.22 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period. The...
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files for Approval for Use of Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations in Canada and the EU
May 05, 2021 08:12 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological...
Point of Care Molecular Diagnostics Market to be Worth $2.32 billion by 2027- Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®
April 01, 2021 07:30 ET
|
Meticulous Market Research Pvt. Ltd.
London, April 01, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Point of Care Molecular Diagnostics Market by Product & Service (Assay, Analyzer, Software, Service),...
COVID-19 Diagnostics Market 2021 | Size to Hit USD 8.04 Billion With 2.7% CAGR by 2027
March 26, 2021 03:09 ET
|
Fortune Business Insights
Pune, India, March 26, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period....
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Emergency Use Authorization With FDA for Use of Its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations
March 24, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting...
Real-world Evidence (RWE) Solutions Market to Reach $3.13 Billion by 2027, Growing at a CAGR of 16.5%, Says Meticulous Research®
March 15, 2021 08:30 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, March 15, 2021 (GLOBE NEWSWIRE) -- According to a new market research report, “Real-world Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application...
In-vitro Diagnostics (IVD) Reagents Market Worth $77.6 billion by 2027, Growing at a CAGR of 7% From 2020, Says Meticulous Research®
March 15, 2021 07:12 ET
|
Meticulous Market Research Pvt. Ltd.
London, March 15, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “In-Vitro Diagnostic Reagents Market by Type (Oligonucleotide, Antibodies, Nucleic Acid Probe), Technology...
AXIM® Biotechnologies Successfully Completes Point-of-Care Clinical Trials on its Rapid COVID-19 Neutralizing Antibody Test
March 08, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting...
COVID-19 Diagnostics Market Size Worth USD 8.04 Billion at 2.7% CAGR; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™
March 01, 2021 06:57 ET
|
Fortune Business Insights
Pune, India, March 01, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period....
COVID-19 Diagnostics Market 2021 Size & Share | Market worth USD 11.40 Billion at 7.9% CAGR by 2027
February 09, 2021 04:33 ET
|
Fortune Business Insights
Pune, India, Feb. 09, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period....